Through our work, we aim to raise awareness and funds for brain cancer research while helping those suffering with a brain tumor have a better quality of life.

Brain Tumor Clinical Trials

Currently, brain tumor vaccines are showing a bright future in the fight against brain tumors.  Brain Tumor Alliance maintains a list and information on all clinical trials in the United States which are currently enrolling patients.

Through Brain Tumor Alliance, you will find information and access to these brain tumor and brain cancer vaccine clinical trials as well as information on the inclusion and exclusion criteria associated with each trial.

Brain Tumor Alliance is dedicated to raising awareness and funding for cutting edge brain tumor research and clinical trials and to providing travel assistance to qualified patients.

Through our work, we intend on not only finding treatments that provide a better quality of life for those suffering with brain cancer, but ultimately a cure for it.

Clinical Trials:

Currently recruiting participants:

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (DCVax®)

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Glioma

Surviving Vaccine Therapy for Patients With Malignant Gliomas

Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas 

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Dendritic Cell Vaccine for Patients With Brain Tumors

Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Dendritic Cell Cancer Vaccine for High-grade Glioma (GBM-Vax)

Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)

Ongoing Trials (but not currently recruiting participants):

Vaccine Therapy in Treating Patients With Malignant Glioma 

Completed Trials:

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

Current Status Unknown - Must be verified:

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Brain Tumor Alliance recommends that you research and discuss your participation in these clinical trials with your doctor prior to proceeding in any of these, or other brain tumor clinical trials.

Get Involved!

Help play your part in eliminating brain cancer by participating in events, making financial contributions, or by hosting your own fundraiser! Join the alliance and help us to increase brain tumor awareness as we work towards the cure.

Learn More